Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery

PHASE3CompletedINTERVENTIONAL

Enrollment

1,090

Participants

Timeline

Start Date

August 31, 1993

Conditions

Respiratory Distress Syndrome

Interventions

DRUG

betamethasone

DRUG

dexamethasone

DRUG

thyrotropin-releasing hormone

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Children's Hospital of Philadelphia

OTHER

lead

National Center for Research Resources (NCRR)

NIH